- Author: Pamela S Kan-Rice
The University of California Office of the President invites comments on a proposed Presidential Policy Use of Externally Supplied Medications in UC Outpatient and Clinic Settings. The policy is proposed to be revised and includes the following key issues:
- The Drug Supply Chain Security Act (DSCSA) is a federal law that requires UC to be able to track and trace all medications given to patients. Currently, there are medications coming into our UC system that we can't track and trace because they are externally supplied by outside pharmacies. This policy would ban the use of medications that were externally supplied outside of our contracted distributors.
- UC has identified that externally...
- Author: Pamela S Kan-Rice
The University invites comments on proposed revisions to the following Academic Personnel Manual policy:
- APM - 016, University Policy on Faculty Conduct and the Administration of Discipline
Summarized below are the proposed key policy revisions that are being distributed for systemwide review.
Key policy revisions
The policy revisions respond to the need to revise APM - 016 to address the handling of simultaneous academic misconduct investigations and personnel actions and include:
- Pause on Academic Personnel Review Actions: At the beginning of a formal investigation of alleged misconduct by a...
- Author: Pamela S Kan-Rice
The University of California Office of the President invites comments on a proposal to rescind the Presidential Policy on Hoverboards. The policy is proposed to be rescinded to address the following key issues:
- The policy was envisioned as a temporary, emergency policy to address fire risks created by individuals charging hoverboard batteries in or on UC properties.
- Since the policy was adopted, the following developments have occurred:
- Underwriter's Laboratories (UL) testing and listing for lithium ion-powered equipment and batteries has become more prescriptive.
- The California Office of the State Fire Marshal released a guidance document (23-003) in April of 2023...